Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2020 2
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Access and benefit-sharing by the European Virus Archive in response to COVID-19.
Sett S, Dos Santos Ribeiro C, Prat C, Haringhuizen G; European Virus Archive principal investigators; Scholz AH. Sett S, et al. Among authors: scholz ah. Lancet Microbe. 2022 Apr;3(4):e316-e323. doi: 10.1016/S2666-5247(21)00211-1. Epub 2021 Nov 16. Lancet Microbe. 2022. PMID: 34806057 Free PMC article. Review.
DSI, the Nagoya Protocol, and Stakeholders' Concerns.
Karger EJ, Scholz AH. Karger EJ, et al. Among authors: scholz ah. Trends Biotechnol. 2021 Feb;39(2):110-112. doi: 10.1016/j.tibtech.2020.09.008. Epub 2020 Nov 19. Trends Biotechnol. 2021. PMID: 33223230 No abstract available.
Benefit-Sharing by Design: A Call to Action for Human Genomics Research.
Mc Cartney AM, Scholz AH, Groussin M, Staunton C. Mc Cartney AM, et al. Among authors: scholz ah. Annu Rev Genomics Hum Genet. 2024 Apr 12. doi: 10.1146/annurev-genom-021623-104241. Online ahead of print. Annu Rev Genomics Hum Genet. 2024. PMID: 38608642 Review.
Multilateral benefit-sharing from digital sequence information will support both science and biodiversity conservation.
Scholz AH, Freitag J, Lyal CHC, Sara R, Cepeda ML, Cancio I, Sett S, Hufton AL, Abebaw Y, Bansal K, Benbouza H, Boga HI, Brisse S, Bruford MW, Clissold H, Cochrane G, Coddington JA, Deletoille AC, García-Cardona F, Hamer M, Hurtado-Ortiz R, Miano DW, Nicholson D, Oliveira G, Bravo CO, Rohden F, Seberg O, Segelbacher G, Shouche Y, Sierra A, Karsch-Mizrachi I, da Silva J, Hautea DM, da Silva M, Suzuki M, Tesfaye K, Tiambo CK, Tolley KA, Varshney R, Zambrano MM, Overmann J. Scholz AH, et al. Nat Commun. 2022 Feb 23;13(1):1086. doi: 10.1038/s41467-022-28594-0. Nat Commun. 2022. PMID: 35197464 Free PMC article.
Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.
Expert round table on acceptance and re-implementation of bacteriophage therapy; Sybesma W, Rohde C, Bardy P, Pirnay JP, Cooper I, Caplin J, Chanishvili N, Coffey A, De Vos D, Scholz AH, McCallin S, Püschner HM, Pantucek R, Aminov R, Doškař J, Kurtbӧke Dİ. Expert round table on acceptance and re-implementation of bacteriophage therapy, et al. Among authors: scholz ah. Antibiotics (Basel). 2018 Apr 23;7(2):35. doi: 10.3390/antibiotics7020035. Antibiotics (Basel). 2018. PMID: 29690620 Free PMC article.